Interpace Diagnostics Group Reports Third Quarter 2017 Financial Results, Business Progress and Recent Accomplishments Nov 13, 2017
Interpace Diagnostics to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results and Business Progress on Monday November 13, 2017 Nov 9, 2017
Interpace Diagnostics Presents Important Data at the World Congress of Gastroenterology at American College of Gastroenterology (ACG) 2017 Oct 23, 2017
Interpace Diagnostics Presents New Data from Over 3,400 Patients Tested with ThyGenX®/ThyraMIR® Oct 18, 2017
Interpace Diagnostics to Present at the Dawson James Securities 3rd Annual Small Cap Growth Stock Conference Oct 17, 2017
Interpace Diagnostics Announces Expansion into New Clinical Area with Launch of Molecular Lung Cancer Test Sep 25, 2017
Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Audit Committee Requirements Sep 20, 2017
